EMA Deciding If Donanemab For Alzheimer’s & Three Other Drugs Merit Fast-Tracking

 
• By Neena Brizmohun
  
Alzheimer's puzzle
Lilly's donanemab is designed to slow Alzheimer’s disease progression • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography